Injection therapy for subacute and chronic low back pain: an updated Cochrane review
- PMID: 19127161
- DOI: 10.1097/BRS.0b013e3181909558
Injection therapy for subacute and chronic low back pain: an updated Cochrane review
Abstract
Study design: A systematic review of randomized controlled trials (RCTs).
Objective: To determine if injection therapy is more effective than placebo or other treatments for patients with subacute or chronic low back pain.
Summary of background data: The effectiveness of injection therapy for low back pain is still debatable. Heterogeneity of target tissue, pharmacological agent, and dosage, generally found in RCTs, point to the need for clinically valid comparisons in a literature synthesis.
Methods: We updated the search of the earlier systematic review and searched the Cochrane Central Register of Controlled Trials, MEDLINE, and EMBASE databases up to March 2007 for relevant trials reported in English, French, German, Dutch, and Nordic languages. We also screened references from trials identified. RCTs on the effects of injection therapy involving epidural, facet, or local sites for subacute or chronic low back pain were included. Studies that compared the effects of intradiscal injections, prolotherapy, or ozone therapy with other treatments were excluded unless injection therapy with another pharmaceutical agent (no placebo treatment) was part of one of the treatment arms. Studies about injections in sacroiliac joints and studies evaluating the effects of epidural steroids for radicular pain were also excluded.
Results: Eighteen trials (1179 participants) were included in this review. The injection sites varied from epidural sites and facet joints (i.e. intra-articular injections, peri-articular injections and nerve blocks) to local sites (i.e. tender-and trigger points). The drugs that were studied consisted of corticosteroids, local anesthetics, and a variety of other drugs. The methodologic quality of the trials was limited with 10 of 18 trials rated as having a high methodologic quality. Statistical pooling was not possible because of clinical heterogeneity in the trials. Overall, the results indicated that there is no strong evidence for or against the use of any type of injection therapy.
Conclusion: There is insufficient evidence to support the use of injection therapy in subacute and chronic low-back pain. However, it cannot be ruled out that specific subgroups of patients may respond to a specific type of injection therapy.
Similar articles
-
Injection therapy for subacute and chronic low-back pain.Cochrane Database Syst Rev. 2008 Jul 16;2008(3):CD001824. doi: 10.1002/14651858.CD001824.pub3. Cochrane Database Syst Rev. 2008. PMID: 18646078 Free PMC article. Review.
-
Injection therapy for subacute and chronic benign low back pain.Cochrane Database Syst Rev. 2000;(2):CD001824. doi: 10.1002/14651858.CD001824. Cochrane Database Syst Rev. 2000. Update in: Cochrane Database Syst Rev. 2007 Jul 18;(2):CD001824. doi: 10.1002/14651858.CD001824.pub2 Update in: Cochrane Database Syst Rev. 2008 Jul 16;(3):CD001824. doi: 10.1002/14651858.CD001824.pub3 PMID: 10796449 Updated. Review.
-
WITHDRAWN: Injection therapy for subacute and chronic benign low-back pain.Cochrane Database Syst Rev. 2007 Jul 18;(2):CD001824. doi: 10.1002/14651858.CD001824.pub2. Cochrane Database Syst Rev. 2007. PMID: 17636686 Review.
-
Injection therapy for subacute and chronic benign low back pain.Spine (Phila Pa 1976). 2001 Mar 1;26(5):501-15. doi: 10.1097/00007632-200103010-00014. Spine (Phila Pa 1976). 2001. PMID: 11242378 Review.
-
The effectiveness of lumbar interlaminar epidural injections in managing chronic low back and lower extremity pain.Pain Physician. 2012 Jul-Aug;15(4):E363-404. Pain Physician. 2012. PMID: 22828691 Review.
Cited by
-
Preclinical development and characterisation of PP353, a formulation of linezolid for intradiscal administration.JOR Spine. 2024 Nov 14;7(4):e70010. doi: 10.1002/jsp2.70010. eCollection 2024 Dec. JOR Spine. 2024. PMID: 39544355 Free PMC article.
-
Current advances in the treatment of myofascial pain syndrome with trigger point injections: A review.Medicine (Baltimore). 2024 Oct 4;103(40):e39885. doi: 10.1097/MD.0000000000039885. Medicine (Baltimore). 2024. PMID: 39465697 Free PMC article. Review.
-
The relationship between changes in pain intensity and functional disability in persistent disabling low back pain during a course of cognitive functional therapy.Scand J Pain. 2024 Oct 3;24(1). doi: 10.1515/sjpain-2024-0040. eCollection 2024 Jan 1. Scand J Pain. 2024. PMID: 39361965
-
The clinical impact of lumbar epidural steroid injections prior to spine surgery for lumbar spinal stenosis.Interv Pain Med. 2022 May 26;1(2):100104. doi: 10.1016/j.inpm.2022.100104. eCollection 2022 Jun. Interv Pain Med. 2022. PMID: 39239369 Free PMC article.
-
Comparative Effectiveness of Epidural Steroid İnjections in Patients With Disc Bulging and Disc Protrusion.Cureus. 2023 Sep 26;15(9):e45994. doi: 10.7759/cureus.45994. eCollection 2023 Sep. Cureus. 2023. PMID: 37900516 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
